Form 4: GoodRx CAO Thomas Chan Executes RSU Vesting

GoodRx Holdings, Inc. Chief Accounting Officer Thomas Chan acquired 5,575 shares through RSU vesting and disposed of 2,838 shares to cover tax obligations.

Summary

• Chief Accounting Officer Thomas Chan exercised restricted stock units (RSUs) for 5,575 shares of Class A Common Stock on May 15, 2026.
• A total of 2,838 shares were withheld by the company to satisfy tax withholding requirements at a price of $2.49 per share.
• Following these transactions, the reporting person holds 3,737 shares of Class A Common Stock directly.
• The transactions were part of scheduled RSU vesting cycles.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents routine administrative equity compensation activity rather than a strategic shift or market-driven trade.

Positives

• The transaction reflects standard equity compensation vesting rather than open-market selling.
• The reporting person maintains a direct equity stake in the company following the tax-related dispositions.

Negatives

• The disposition of 2,838 shares was required to cover tax liabilities associated with the vesting event.

Risks

• Future share price volatility may impact the value of remaining unvested restricted stock units.

Future Outlook

The filing does not provide forward-looking financial guidance, as it is a routine disclosure of insider equity transactions.

Industry Context

StockSavvy.ai notes that routine RSU vesting and tax-related share withholding are standard corporate governance practices for executive compensation and do not typically signal a change in management sentiment regarding company performance.

Comparison to Industry Standards

• The transaction structure is consistent with standard equity compensation practices observed in the healthcare technology sector.
• The use of 'sell-to-cover' for tax obligations is a common practice among executives at publicly traded companies like GoodRx.

Stakeholder Impact

• Minimal impact on shareholders as the transaction is a standard component of executive compensation packages.

Next Steps

• Future vesting of remaining restricted stock units subject to continued service requirements.

Key Dates

Keywords

GoodRx, GDRX, Insider Trading, Form 4, Equity Compensation, Restricted Stock Units